Although compounded GLP-1 medications are not banned, they are generally not recommended even in small doses, Pinto says
Learn more about Zepbound Weight Loss in Florida Mounjaro is a tirzepatide-based medication commonly associated with type 2 diabetes care
By contrast with Novo, Lilly posted stronger-than-expected 2026 guidance last week, as its GLP-1s have been more effective than Novo's offerings, while also being cost-competitive
Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R, Azen SP
Our program is tailored to each individuals needs and includes regular check-ins with a healthcare provider at our office to monitor progress and adjust the program as needed